GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a significant focus in healthcare investigation, largely due to its remarkable impact on treating ailments such as second type diabetes and excess body fat. Ongoing studies have demonstrated that in addition to glucose control, GLP-1 drugs offer potential for circula